INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines tohelp treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that first quarter 2025 financial results will be released after the market close on May 13, 2025. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.

https://mma.prnewswire.com/media/2310866/INOVIO_v1_Logo.jpg

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancers, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

ContactsMedia: Jennie Willson, (267) 429-8567, communications@inovio.comInvestors: Peter Vozzo - ICR Healthcare, (443) 213-0505,investor.relations@inovio.com

https://c212.net/c/img/favicon.png?sn=PH74580&sd=2025-04-29

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-first-quarter-2025-financial-results-on-may-13-2025-302440001.html

SOURCE INOVIO Pharmaceuticals, Inc.

https://rt.newswire.ca/rt.gif?NewsItemId=PH74580&Transmission_Id=202504290805PR_NEWS_USPR_____PH74580&DateId=20250429

COMTEX_465032714/1005/2025-04-29T08:05:31